1. A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer 
Paul Devroey, M.D., Ph.D., Antonio Pellicer, M.D., Anders Nyboe Andersen, M.D., Joan-Carles Arce, M.D., Ph.D. 
Fertility and Sterility 
Volume 97, Issue 3, Pages (March 2012)
DOI: /j.fertnstert
Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions

2. Figure 1
Trial flow chart and disposition of patients by trial visit. ITT = intention-to-treat; PP = per-protocol.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions

3. Figure 2
Pregnancy and live birth data for the fresh cycle per started cycle for (A) the per-protocol (PP) population and (B) the intention-to-treat (ITT) population. Pregnancy and live birth data for the fresh cycle per cycle with transfer for (C) the PP population and (D) the ITT population.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions

4. Figure 3
Ongoing pregnancy rate in the fresh cycle by oocytes retrieved according to treatment group and end-of-stimulation P levels ≤4 nmol/L and >4 nmol/L (intention-to-treat population).
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions